PFE Dec 2025 22.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:58AM EDT. Market open.
Loading interactive chart…
- Zacks
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
- Zacks
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- Zacks
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
© 2024 Yahoo. All rights reserved.